BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 27283259)

  • 1. Persistent Nonalcoholic Fatty Liver Disease Increases Risk for Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW; Guallar E; Cho J; Gwak GY
    Gastroenterology; 2016 Sep; 151(3):481-488.e1. PubMed ID: 27283259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.
    Zheng J; Zhou Y; Zhang K; Qi Y; An S; Wang S; Zhao X; Tang YD
    BMC Cardiovasc Disord; 2018 Jul; 18(1):147. PubMed ID: 30012085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Nonalcoholic Fatty Liver Disease and Subclinical Atherosclerosis Among Young Mexican Americans.
    Gill C; Vatcheva KP; Pan JJ; Smulevitz B; McPherson DD; Fallon M; McCormick JB; Fisher-Hoch SP; Laing ST
    Am J Cardiol; 2017 Jun; 119(11):1717-1722. PubMed ID: 28395890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.
    Xin Z; Zhu Y; Wang S; Liu S; Xu M; Wang T; Lu J; Chen Y; Zhao Z; Wang W; Ning G; Bi Y; Xu Y; Li M
    Liver Int; 2020 Apr; 40(4):806-814. PubMed ID: 31820847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
    Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
    Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically healthy obesity and the risk for subclinical atherosclerosis.
    Kim TJ; Shin HY; Chang Y; Kang M; Jee J; Choi YH; Ahn HS; Ahn SH; Son HJ; Ryu S
    Atherosclerosis; 2017 Jul; 262():191-197. PubMed ID: 28385392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.
    Bhatia L; Scorletti E; Curzen N; Clough GF; Calder PC; Byrne CD
    Atherosclerosis; 2016 Mar; 246():13-20. PubMed ID: 26748347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
    Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
    Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up.
    Fracanzani AL; Tiraboschi S; Pisano G; Consonni D; Baragetti A; Bertelli C; Norata D; Valenti L; Grigore L; Porzio M; Catapano A; Fargion S
    Atherosclerosis; 2016 Mar; 246():208-13. PubMed ID: 26803429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity.
    Puig J; Blasco G; Daunis-I-Estadella J; Loshuertos E; Codina J; Cuba V; Ortiz R; Xifra G; Ricart W; Pedraza S; Federici M; Fernández-Real JM
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):180-6. PubMed ID: 25510350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance.
    Kim SK; Choi YJ; Huh BW; Park SW; Lee EJ; Cho YW; Huh KB
    J Clin Endocrinol Metab; 2014 May; 99(5):1879-84. PubMed ID: 24512497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.
    Yu X; Chen C; Guo Y; Tong Y; Zhao Y; Wu L; Sun X; Wu X; Song Z
    Ann Med; 2021 Dec; 53(1):1621-1631. PubMed ID: 34498502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
    Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
    Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
    Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis.
    Ampuero J; Gallego-Durán R; Romero-Gómez M
    Rev Esp Enferm Dig; 2015 Jan; 107(1):10-6. PubMed ID: 25603326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome.
    Kim HC; Kim DJ; Huh KB
    Atherosclerosis; 2009 Jun; 204(2):521-5. PubMed ID: 18947828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.